Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAM: CHF 718 pMDI dose-ranging study in asthma
NCT03084718Phase 2Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jul 2017
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of beclomethasone dipropionate in asthma, sponsored by Chiesi Farmaceutici S.p.A.. Started Jul 2017; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
asthma
Beyond the preview
Go deeper on NCT03084718.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03084718.